The DOI matches its Crossref record; the references it cites are not checked yet.
Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema
Abstract
Angioedema (AE) associated with angiotensin-converting enzyme inhibitors (ACEi) is a rare, but potentially life-threatening adverse reaction. Several studies have suggested that bradykinin (BK) is responsible for ACEi-induced AE, but the mechanism remains unclear. We investigated the metabolism of BK and des-Arg9-BK in the serum of 20 patients with a history of ACEi-associated AE and 21 control (C) subjects. Synthetic BK was incubated with the sera for various periods of time and residual BK and generated des-Arg9-BK were quantified by specific and sensitive enzyme immunoassays. No significant difference of half-life (t1/2) of both BK and des-Arg9-BK could be measured between C subjects and patients with AE (AE) in absence of ACEi. However, an analysis according to the prolonged (+) or not (-) t1/2 of des-Arg9-BK allowed a new stratification of C subjects and AE patients in four subgroups. The preincubation of sera with enalaprilat at a concentration inhibiting ACE significantly prevented the rapid degradation of BK and des-Arg9-BK in these four subgroups. In presence of ACEi, a subgroup (50%) of AE patients (AE + ) had a particularly significant rise of the t1/2 of des-Arg9-BK. Once ACE was inhibited, the concentration or the nature of the ACEi had no significant effect on the t1/2 of des-Arg9-BK. However, a test dilution of AE + sera with a control (C) serum showed that an enzyme defect rather than a circulating inhibitor could be responsible for the abnormal metabolism of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During ACEi, an increased proportion of bradykinin is degraded to des-Arg 9 -bradykinin via the kininase I pathway 12 (Figure 1).”
From Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema (2008) · cites this paper as [12]
In the citing paper
“However, APP activity has not been found to be decreased in all of the case subjects with angioedema compared with control subjects.12,15”
From Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema (2008) · cites this paper as [12]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 28 · Cited by 78
Research works printed but not linked: 3
- Décarie, 1996, Serum interspecies differences in metabolic pathways of BK and [des-Arg9]BK: influence of enalaprilat, Am. J. Physiol., 270, H1340
- Moore, J.W., Pearson, R.G., 1981. Complex reactions. In: Moore, J.W., Pearson, R.G. (Eds.), Kinetics and Mechanism. Wiley, New York, pp. 284–296.
- White, G.C., Marder, V.J., Colman, R.W., Hirsh, J., Salzman, E.W., 1994. Approach to the bleeding patient. In: Colman, R.W., Hirsh, J., Marder, V.J., Salzman, E.W. (Eds.), Hemostasis and Thrombosis: Basic Principles and Clinical Practice. JB Lippincott, Philadelphia, pp. 1134–1147.
Metadata
- Authors
- Blais, C., Rouleau, J.-L., Brown, N. J., Lepage, Y., Spence, D., Munoz, C., Friborg, J., Geadah, D., Gervais, N., & Adam, A.
- Affiliations
- Université de Montréal (CA)
- Montreal Heart Institute (CA)
- Vanderbilt University Medical Center (US)
- Robarts Research Institute (CA)
- Hôpital Maisonneuve-Rosemont (CA)
- Corresponding author
- Adam, Albert
- Venue
- Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 1999-09
- Volume
- 43
- Issue
- 2-3
- Pages
- 293-302
- ISSN
- 0162-3109 (ISSN-L)
- OpenAlex
- W2016105079
- Semantic Scholar
- 0e9e278aa7ddfaa9410457cad906dea1fbf85d84
- Cited by
- 78
- References
- 28
- Citations by year
- 2025: 1 · 2024: 2 · 2021: 3 · 2020: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 6
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Merck Canada
- Fonds de Recherche du Québec - Santé
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pineapple and bromelain studies
- Keywords
- bradykinin, des-Arg9-bradykinin, bradykinin metabolism, bradykinin B1 receptor, enalaprilat, angiotensin-converting enzyme inhibition, inflammation
- MeSH terms
- Adult, Aged, Angioedema, Angiotensin-Converting Enzyme Inhibitors, Lysine Carboxypeptidase, Bradykinin, Dose-Response Relationship, Drug, Female, Half-Life, Humans, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. https://app.cochat.ai/papers/10.1016/s0162-3109(99)00133-2
- The paper
- Blais, C., Rouleau, J.-L., Brown, N. J., Lepage, Y., Spence, D., Munoz, C., Friborg, J., Geadah, D., Gervais, N., & Adam, A. (1999). Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology. https://doi.org/10.1016/s0162-3109(99)00133-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.